Haleon margin reset and weak sales beyond oral care prompt Jefferies downgrade to hold
Haleon PLC (LSE:HLN, NYSE:HLN), the consumer health group behind Sensodyne and Centrum, has been downgraded by Jefferies to hold from…
4,105€
0,49%
Echtzeit-Aktienkurs HALEON PLC LS 1,25
Bid:
Ask:
Nachrichten zur HALEON PLC LS 1,25 Aktie
Haleon faces calls for a reset as brokers question growth outlook
Haleon PLC (LSE:HLN, NYSE:HLN) received a Deutsche Bank upgrade despite a target cut, while RBC lowered its target and JPMorgan…
Haleon tipped to cut sales growth guidance as cough and cold season clouds outlook
Haleon PLC (LSE:HLN, NYSE:HLN), the consumer healthcare group, is expected to reduce its 2026 organic sales growth guidance after UBS…
Deutsche Bank stays bearish on Haleon as growth headwinds mount
Deutsche Bank has reiterated its sell rating on Haleon PLC (LSE:HLN, NYSE:HLN), warning that the consumer health group faces persistent pressure…
Haleon slides as quality of growth questioned
Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 2.9% to 368.7p after the consumer healthcare group reported improving second-quarter sales but left its…
Futura swaps Haleon for Market Performance Group to drive US Eroxon sales
Share in Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) rose 19% to 0.6p after it ended its US partnership with consumer health giant Haleon…
Haleon performance might be stronger than you think, analyst repeats buy rating
Jefferies still sees upside in Haleon PLC (LSE:HLN, NYSE:HLN), even after cutting its price target, arguing the consumer healthcare group’s…
Haleon performance might be stronger than you think, analyst repeats buy rating
Jefferies still sees upside in Haleon PLC (LSE:HLN, NYSE:HLN), even after cutting its price target, arguing the consumer healthcare group’s…
Haleon plc (HLN) Q1 2026 Sales/Trading Call Transcript
…
Haleon hit by weak cold season but strong toothpaste sales keep outlook on track
Haleon PLC (LSE:HLN, NYSE:HLN) reported modest sales growth in the first quarter as strength in oral health was offset by…
Haleon set for slow start from weak flu season, with Middle East cushion
Haleon PLCs (LSE:HLN, NYSE:HLN) first-quarter sales at the end of next month come with analysts expecting a subdued start to the…
Haleons weaker sales make mid-term targets not look credible
Haleon PLC faces a familiar market dilemma after solid profit delivery was overshadowed by weaker than expected sales growth and cautious…
Haleon hit by channel shift concerns
Haleon PLC (LSE:HLN, NYSE:HLN) shares dropped slightly after Deutsche Bank reiterated its sell rating on the maker of Sensodyne and Panadol, warning…
Citi maintains sell on Haleon, cuts target price on FX optimism and US channel concerns
Citi has reiterated its sell rating on Haleon PLC (LSE:HLN, NYSE:HLN) and trimmed its price target from 340p to 335p, warning…
Haleon poised to deliver solid margin growth despite weaker cold season
Night Nurse maker Haleon PLC (LSE:HLN, NYSE:HLN) is expected to report a strong finish to 2025 next month, with investors watching…
Haleon not out of the woods yet, with analysts saying questions still remain
Haleon PLCs (LSE:HLN, NYSE:HLN) third-quarter numbers were in line with expectations and the outlook was maintained, but analysts at Barclays…
Are Haleons headaches set to ease? Heres one leading banks take
Haleon PLCs (LSE:HLN, NYSE:HLN) management could be forgiven for feeling like pharmacists rearranging the medicine cabinet while the queue outside…
Haleon’s resilience and brand power shine through in Q2
Barclays has repeated its overweight call and 430p price target for Haleon PLC (LSE:HLN, NYSE:HLN) following a solid set of second-quarter results.…
Haleon’s resilience and brand power shine through in Q2
Barclays has repeated its overweight call and 430p price target for Haleon PLC (LSE:HLN, NYSE:HLN) following a solid set of second-quarter results.…
Haleon shares hit by weaker US vitamin sales
Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 1% after the toothpaste and painkillers maker reported slightly stronger first-quarter growth than expected but...…
Does defensive Haleon have a cure for the current market blues?
Citi believes Haleon PLC (LSE:HLN, NYSE:HLN) is well positioned for the current uncertain climate, describing the consumer healthcare group as a…
Haleon buys £170m of shares as Pfizer offloads final stake
Haleon PLC (LSE:HLN, NYSE:HLN) has bought roughly £170 million of its shares back from former parent company Pfizer Inc (NYSE:PFE, ETR:PFE). The…